Apnimed, Inc. APMD
16.09 USD -1.16 (-6.70%)
Regular-session close
16.09 0.00 0.00%
After hours · Nov 20, 4:01 PM ET
15.95 Day range 17.73
14.16 52-week range 32.55
- YTD
- -35.64%
- 1 year
- -35.64%
News
globenewswire.com New National Survey Found Many People With Sleep Apnea Struggle to Stay on Treatment The Untreated OSA Initiative Survey, sponsored by Apnimed, gathered responses from 2,505 adults with obstructive sleep apnea (OSA), bed partners, and clinicians The survey was developed in…benzinga.com Apnimed Q3 EPS $(1.05) Misses $(0.59) Estimate, Sales $2.480M Down From $8.802M YoY Apnimed (NASDAQ:APMD) reported quarterly losses of $(1.05) per share which missed the analyst consensus estimate of $(0.59) by 77.97 percent. This is a 42.62 percent increase over losses of $(1.83)…
globenewswire.com Apnimed Reports Third Quarter 2026 Financial Results and Provides Corporate Update New Drug Application (“NDA”) for AD109, with a proposed proprietary name Oxnimbi™ (aroxybutynin and atomoxetine) tablets, for oral use, remains under U.S. Food and Drug Administration (“FDA”) review…
